LifeMD vs TrimRx (2026): prices, structure, verdict

On tirzepatide, TrimRx↗ is cheaper: $349 versus $597 a month all-in — a $248 monthly gap, $2,976 across a year of maintenance dosing.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, TrimRx is cheaper: $299 versus $348 a month all-in — a $49 monthly gap, $588 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

LifeMD: the record, condensed

Start with the load-bearing figure: $597 a month, all-in, is what LifeMD charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

A required $149/month membership is part of the deal, and part of the figure above: $448 of medication plus $149 of platform equals the $597 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #17 of 17 in the verified tirzepatide index — $382/month above the floor (NexLife↗, $215) — and sits $148 over the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $7,164.

LifeMD’s semaglutide program bills $348 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at LifeMD is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

A required $149/month membership is part of the deal, and part of the figure above: $199 of medication plus $149 of platform equals the $348 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #20 of 20 verified programs, with the floor $215/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $1 a month. A year at this figure: $4,176 monthly-billed.

Operationally at LifeMD: shipping included; commitment program fee recurs monthly; cancellation program fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: 50 states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the LifeMD page · visit LifeMD ↗

TrimRx: the record, condensed

Start with the load-bearing figure: $349 a month, all-in, is what TrimRx charges for tirzepatide at the 10 mg basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #11 of 17 in the verified tirzepatide index — $134/month above the floor (NexLife, $215) — and sits $100 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,188.

Start with the load-bearing figure: $299 a month, all-in, is what TrimRx charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes TrimRx unusually easy to compare and unusually easy to leave.

To place the number: #17 of 20 verified programs, with the floor $166/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $50 a month. A year at this figure: $3,588 monthly-billed.

Operationally at TrimRx: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the TrimRx page · visit TrimRx ↗

Tirzepatide: the duel in full

The tirzepatide arithmetic between these two is short: $349 (TrimRx) against $597 (LifeMD). $248 a month sounds survivable; $2,976 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $248 gap is exactly what it appears to be.

LifeMD’s total includes a mandatory $149/month membership; TrimRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Semaglutide: the duel in full

Put the two semaglutide figures side by side and hold them there: TrimRx at $299, LifeMD at $348 — a $49 monthly spread that compounds to $588 over a maintenance year and $1,176 over two.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $49 gap is exactly what it appears to be.

LifeMD’s total includes a mandatory $149/month membership; TrimRx has none. The all-in figures above neutralize that difference — but the membership side has an exit consideration the other lacks: a fee that recurs until you affirmatively cancel it.

Translate the $248/month spread into medication: $2,976 a year equals roughly 8.5 months of therapy at the cheaper program’s rate. That is the honest unit for gaps in this market — months of treatment, not abstract dollars — and it is why small-looking monthly differences decide long courses.

On best published rate — the lower of each program’s month-to-month price and its labeled 12-month-plan rate, which is the sort most price roundups quietly run — the duel reads: LifeMD $597/mo month-to-month versus TrimRx $349/mo month-to-month. Same winner on both bases — TrimRx leads whether you compare month-to-month prices or committed-plan rates, which makes this one of the cleaner verdicts in the index. Prepaid rates are upfront commitments with refund terms to verify before they count.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: LifeMD $1,791 monthly; TrimRx $1,047 monthly — best path favors TrimRx by $744. 6 months: LifeMD $3,582 monthly; TrimRx $2,094 monthly — best path favors TrimRx by $1,488. 12 months: LifeMD $7,164 monthly; TrimRx $4,188 monthly — best path favors TrimRx by $2,976. 24 months: LifeMD $14,328 monthly; TrimRx $8,376 monthly — best path favors TrimRx by $5,952.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

The same clock, on semaglutide

3 mo: LifeMD $1,044 vs TrimRx $897 — $147 to TrimRx. 6 mo: LifeMD $2,088 vs TrimRx $1,794 — $294 to TrimRx. 12 mo: LifeMD $4,176 vs TrimRx $3,588 — $588 to TrimRx. 24 mo: LifeMD $8,352 vs TrimRx $7,176 — $1,176 to TrimRx.

Same rules as above: prepaid figures are upfront commitments, and the 24-month lines extend the 12-month rate as a stated assumption. Where the two molecules crown different winners between these two programs, that split is itself the finding — molecule choice and provider choice are separate decisions.

§ Structure vs structure

Everything besides the price

Coverage: LifeMD publishes “50 states”; TrimRx publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Neither names its pharmacy publicly — the single most useful disclosure in this category, missing on both sides; ask each, in writing, before paying either.

Exit terms: LifeMD — program fee recurs monthly; program fee recurs until cancelled. TrimRx — none month-to-month; check terms before prepaying.

Insurance: only LifeMD does coverage work — decisive if there is any chance your plan covers a brand GLP-1, because a covered prescription beats both cash paths on this page.

Evidence: LifeMD third-party reported (captured 2026-08-05); TrimRx source-verified (2026-08-05).

A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.

In the full tirzepatide index these two sit at #17 and #11 of 17: between them lie 5 other programs, and the whole ladder is at cheapest tirzepatide providers. In the full semaglutide index these two sit at #20 and #17 of 20: between them lie 2 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between LifeMD and TrimRx

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (LifeMD: program fee recurs until cancelled; TrimRx: check terms before prepaying) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings